 Juan Monteverde, founder and managing partner at Monteverde Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Principia Biopharma Inc. PRNB or the Company Nasdaq: PRNB relating to its sale to Sanofi. Under the terms of the agreement, PRNB shareholders will receive 100.00 in cash for each share of PRNB stock they own. 